Celyad Oncology SA (CLYYF)
0.315
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Celyad Oncology Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.948M |
| May 30, 2024 | 2.948M |
| May 29, 2024 | 2.948M |
| May 28, 2024 | 2.948M |
| May 24, 2024 | 2.948M |
| May 23, 2024 | 2.948M |
| May 22, 2024 | 2.948M |
| May 21, 2024 | 2.948M |
| May 20, 2024 | 2.948M |
| May 17, 2024 | 2.948M |
| May 16, 2024 | 2.948M |
| May 15, 2024 | 2.948M |
| May 14, 2024 | 2.948M |
| May 13, 2024 | 2.948M |
| May 10, 2024 | 2.948M |
| May 09, 2024 | 2.948M |
| May 08, 2024 | 2.948M |
| May 07, 2024 | 2.948M |
| May 06, 2024 | 2.948M |
| May 03, 2024 | 4.088M |
| May 02, 2024 | 4.088M |
| May 01, 2024 | 4.088M |
| April 30, 2024 | 4.088M |
| April 29, 2024 | 4.088M |
| April 26, 2024 | 4.088M |
| Date | Value |
|---|---|
| April 25, 2024 | 4.088M |
| April 24, 2024 | 4.088M |
| April 23, 2024 | 4.088M |
| April 22, 2024 | 4.088M |
| April 19, 2024 | 4.088M |
| April 18, 2024 | 4.088M |
| April 17, 2024 | 4.088M |
| April 16, 2024 | 4.088M |
| April 15, 2024 | 4.088M |
| April 12, 2024 | 4.088M |
| April 11, 2024 | 4.088M |
| April 10, 2024 | 4.088M |
| April 09, 2024 | 4.088M |
| April 08, 2024 | 4.088M |
| April 05, 2024 | 4.088M |
| April 04, 2024 | 4.088M |
| April 03, 2024 | 4.088M |
| April 02, 2024 | 4.088M |
| April 01, 2024 | 4.088M |
| March 28, 2024 | 5.166M |
| March 27, 2024 | 5.166M |
| March 26, 2024 | 5.166M |
| March 25, 2024 | 5.166M |
| March 22, 2024 | 5.166M |
| March 21, 2024 | 5.166M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.198M
Minimum
May 26 2023
97.99M
Maximum
Dec 08 2021
40.27M
Average
10.64M
Median
Sep 05 2023
Enterprise Value Benchmarks
| Galapagos NV | -2.010B |
| UCB SA | 28.46B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 231.17M |
| MDxHealth SA | 96.70M |